Compare MIST & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | HYMC |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Canada | United States |
| Employees | N/A | 51 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 2.8B |
| IPO Year | 2019 | N/A |
| Metric | MIST | HYMC |
|---|---|---|
| Price | $1.03 | $32.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 3.6M |
| Earning Date | 03-20-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,653.36 | N/A |
| Revenue Next Year | $12.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $2.30 |
| 52 Week High | $3.06 | $58.73 |
| Indicator | MIST | HYMC |
|---|---|---|
| Relative Strength Index (RSI) | 24.45 | 42.84 |
| Support Level | N/A | $30.67 |
| Resistance Level | $2.01 | $57.24 |
| Average True Range (ATR) | 0.12 | 3.17 |
| MACD | -0.06 | -0.96 |
| Stochastic Oscillator | 0.00 | 20.11 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Hycroft Mining Holding Corp is a United States-based gold and silver exploration-stage issuer. The company owns and is focused on developing its property, the Hycroft Mine, located northwest of Winnemucca, Nevada.